Area of research
Orthopedics and Sports Medicine · Nephrology
Research interest
Research interests include Medicine, Osteoporosis, Osteoarthritis, Internal medicine, Intensive care medicine, and Placebo.
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement
Bone status in patients with chronic hypoparathyroidism: results from the Italian HypoparaNET database
POS1427 ALTERED MITOCHONDRIAL BIOENERGETICS IN HYPOPHOSPHATASIA AND THE INFLUENCE OF EFZIMFOTASE ALFA
A consensus statement on the management of vertebral fractures in CKD stages G4–G5D
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review
Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database
Possible role of bone turnover markers in the diagnosis of adult hypophosphatasia
7773 Increased Fragility of Bone Over Timein Female Patients with Chronic Hypoparathyroidism: Real-world Data from the Italian Cohort
Osteoporosis pain management in Italy
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
Management of patients at very high risk of osteoporotic fractures through sequential treatments
Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia
Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop
Alternative and complementary therapies in osteoarthritis and cartilage repair
Vitamin K and Osteoporosis
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial
The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study